Evaluation of lipid profiles in patients treated with capecitabine
TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.47, sa.4, ss.1206-1209, 2017 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 47 Sayı: 4
- Basım Tarihi: 2017
- Doi Numarası: 10.3906/sag-1607-53
- Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.1206-1209
- Anahtar Kelimeler: Capecitabine, triglycerides, cholesterol, INDUCED SEVERE HYPERTRIGLYCERIDEMIA, OF-THE-LITERATURE, CHEMOTHERAPY
- Çukurova Üniversitesi Adresli: Evet
Özet
Background/aim: Capecitabine is a prodrug of 5-fluorouracil and has shown significant antitumor activity. The main adverse effects are hand-foot syndrome, diarrhea, and dermatitis. In recent years, hypertriglyceridemia has been reported in patients treated with capecitabine. Dyslipidemia is a rare but important side effect of capecitabine. The aim of this study is to examine the changes in lipid levels during capecitabine treatment and to raise awareness of pharmacovigilance.